SlideShare a Scribd company logo
.
ATOPIC
DERMATITIS
1
Dermatitis: greek word- derma +
itis = INFALMMATION OF SKIN
Etymology:
Atopic derived
from atopia in
greek =
UNUSUALNESS
2
AN ITCHY, CHRONIC OR
CHRONICALLY RELAPSING SKIN
CONDITION OFTEN STARTING EARLY
IN CHILHOOD WITH RASH
CHARACTERIZED BY ERYTHEMA ,
ITCHY PAPULES/ PAPULOVESICLES
WHICH MAY BECOME EXCORIATED
AND LICHENIFIED .
DEFINITION
3
Inside outside model Outside inside model
Skin barrier dysfunction
Immunologic abnormality
in skin
Skin barrier
dysfunction
Epicutaneous
allergen
penetration
Immune system
activation
5
Etiopathgenesis
Etiopathogenesis
6
Atopic
dermatitis
Genetics
Immune
dysregulation
Triggers
Microbial
colonizatiom
Hygiene
hypothesis
Hygiene Hypothesis
13
 Early childhood infections caused by unhygienic
contact with older siblings confers protection from
development of allergic diseases
 Farm effect- children living on farms, having contact
with farm animals, drinking unprocessed cow`s
milk, increased exposure to microbes have less
incidence of AD and asthma.
Trigger factors
14
1) Changes in temperature
2) Sweating
3) Decrease in huminity
4) Contact with irritants
5) Aeroallergens
6) Food allergens
7) Emotional stress
8) harmones
Clinical
features
Atopic
dermatitis
Infantile
phase
• Birth to 2
years
• Cheeks
• chin
• forehead
Childhood
phase
• to 12
2
years
• Elbow and
knee folds
• Wrists
• ankles
Adult
phase
• 12 years to
adults
• Flexural
lichenifi
15
Infantile phase
16
Childhood phase
17
Adult phase
19
Pityriasis alba
20
Dirty neck appearence
22
Hanifin & Rajka criteria for the diagnosis of AD
25
Major criteria( must have three or more)
1. Pruritus
2. Typical morphology & distribution
 Facial/extensor involvement in infants & children
 Flexural lichenification in adults
3. Chronic or chronically relapsing dermatitis
4.Personal or family history of atopy(Asthma, allergic
rhinitis, atopic dermatitis)
The UK refinement of Hanifin & Rajka’s
diagnostic criteria of atopic dermatitis(Eczema)
28
Essential criteria
An itchy skin condition(or parental report of scratching or
rubbing in a child)
Plus three more or following:
1. Onset below age of 2 years(not used if child is under 4
years)
2. History of skin crease involvement(including cheeks in
children under 10 years)
3. History of a generally dry skin
4. Personal history of other atopic disease(or history of any
atopic disease in a first-degree relative in children under 4
years)
5. Visible flexural dermatitis(or dermatitis of cheeks/forehead
& outer limbs in children under 4 years)
Millennium criteria
29
Mandatory criteria(must be fulfilled)
1. Allergen specific IgE
Principal criteria(must have two or more)
1. Pruritis
2. Typical morphology & distribution
3. Chronic & relapsing course
33
b) Age related characteristics
 Infantile phase-starts on scalp & face, often spreads to
trunk & extremity
 Childhood phase- neck, flexural surface of arms & legs
 Adolescent/adult phase-tendency to be severe, on upper
half of the body
(iii) Chronic or chronically relapsing course:
 More than 2 months in infancy
 More than 6 months in childhood, adolescence &
adulthood
AMERICAN ACADEMY OF DERMATILOGY
34
Guidelines of care for
management of AD
Recommendation for non pharmacologic interventions for the
treatment of atopic dermatitis
35
 Moisturizers should be an integral part of the treatment.
 Bathing is suggested for the patient with AD as part of
treatment &maintenance
 Moisturizers should be applied soon after bathing
 Limited use of non soap cleansers is recommended
 The additions of oils, emollients & most other additives to
bath waters cannot be recommended
 Use of wet-wrap therapy with or without a topical
corticosteroid can be recommended for patient with
moderate to severe AD to decrease disease severity &
water loss during flares.
Recommendation for the use of topical
corticosteroids for the treatment of atopic dermatitis.
36
 Recommended for AD-affected individuals who have
failed to respond to good skin care & regular use of
emollients alone.
 A variety of factors should be considered including patient
age, body area , & other patient factors such as degree of
xerosis, patient preference & cost of medication
 Twice daily application of corticosteroids is generally
recommended
 Proactive intermittent use of topical corticosteroids as
maintenance therapy(1-2 times/wk) on area that
commonly flare is recommended to help prevent relapses
& is more effective than use of emollients alone
39
Topical antimicrobials and antiseptics
40
Except for bleach baths with intranasal mupirocin, no
topical antistaphylococcal treatment has been shown
to be clinically helpful in patient with AD & is not
routinely recommended.
In patient with moderate to severe AD & clinical signs
of secondary bacterial infection, bleach baths &
intranasal mupirocin may be recommended to
reduce disease severity
Topical antihistamines
41
The use of topical antihistamines for the treatment of
patients with atopic dermatitis is not recommended
because of the risk of absorption & of contact
dermatitis.

More Related Content

Similar to المستند (4).docx

ATOPIC DERMATITIS RASHI.pptx
ATOPIC DERMATITIS RASHI.pptxATOPIC DERMATITIS RASHI.pptx
ATOPIC DERMATITIS RASHI.pptx
DeepikaKothari9
 
9. Eczema & dermatitis
9. Eczema & dermatitis9. Eczema & dermatitis
9. Eczema & dermatitis
Dr.Bijay Yadav
 
ATOPIC DERMATITIS.pptx
ATOPIC DERMATITIS.pptxATOPIC DERMATITIS.pptx
ATOPIC DERMATITIS.pptx
PranavKohli7
 
小兒異位性皮膚炎.pptx
小兒異位性皮膚炎.pptx小兒異位性皮膚炎.pptx
小兒異位性皮膚炎.pptx
ssuser2b14431
 
Child with skin disorder
Child with skin disorderChild with skin disorder
Child with skin disorder
NEHA MALIK
 
Atopic dermatitis. Presentation in pediatric case
Atopic dermatitis. Presentation in pediatric caseAtopic dermatitis. Presentation in pediatric case
Atopic dermatitis. Presentation in pediatric case
AnjaliSahare
 
Disorders of skin
Disorders of skinDisorders of skin
Disorders of skin
Aakanksha Bajpai
 
Atopic dermatitis by Dr.Gamal Soltan
Atopic dermatitis by Dr.Gamal SoltanAtopic dermatitis by Dr.Gamal Soltan
Atopic dermatitis by Dr.Gamal Soltan
gamal sultan
 
Ethics & Dermatology
Ethics & Dermatology Ethics & Dermatology
Ethics & Dermatology
rashmirithusha
 
urticaria and skin allergy tests.pptx
urticaria and skin allergy tests.pptxurticaria and skin allergy tests.pptx
urticaria and skin allergy tests.pptx
ssuser907f24
 
pyoderma.pptx
pyoderma.pptxpyoderma.pptx
pyoderma.pptx
Jehoashviji
 
Atopic dermatitis(Eczema)
Atopic dermatitis(Eczema)Atopic dermatitis(Eczema)
Atopic dermatitis(Eczema)
dr raza
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
Jinumol Jacob
 
Skin infection .pdf
Skin infection .pdfSkin infection .pdf
Skin infection .pdf
UVAS
 
ATOPIC DERMATITIS in children. dx and tx
ATOPIC DERMATITIS in children. dx and txATOPIC DERMATITIS in children. dx and tx
ATOPIC DERMATITIS in children. dx and tx
ogadatv
 
AD.pptx
AD.pptxAD.pptx
7 Dermatitis.pptx
7 Dermatitis.pptx7 Dermatitis.pptx
7 Dermatitis.pptx
EstibelMengist
 
ATOPIC DERMATITIS, diagnosis &management
ATOPIC DERMATITIS, diagnosis &managementATOPIC DERMATITIS, diagnosis &management
ATOPIC DERMATITIS, diagnosis &management
ogadatv
 
Leprosy_٢.pptx
Leprosy_٢.pptxLeprosy_٢.pptx
Leprosy_٢.pptx
bhmMhmm
 

Similar to المستند (4).docx (20)

ATOPIC DERMATITIS RASHI.pptx
ATOPIC DERMATITIS RASHI.pptxATOPIC DERMATITIS RASHI.pptx
ATOPIC DERMATITIS RASHI.pptx
 
9. Eczema & dermatitis
9. Eczema & dermatitis9. Eczema & dermatitis
9. Eczema & dermatitis
 
ATOPIC DERMATITIS.pptx
ATOPIC DERMATITIS.pptxATOPIC DERMATITIS.pptx
ATOPIC DERMATITIS.pptx
 
Dermatitis atópica
Dermatitis atópicaDermatitis atópica
Dermatitis atópica
 
小兒異位性皮膚炎.pptx
小兒異位性皮膚炎.pptx小兒異位性皮膚炎.pptx
小兒異位性皮膚炎.pptx
 
Child with skin disorder
Child with skin disorderChild with skin disorder
Child with skin disorder
 
Atopic dermatitis. Presentation in pediatric case
Atopic dermatitis. Presentation in pediatric caseAtopic dermatitis. Presentation in pediatric case
Atopic dermatitis. Presentation in pediatric case
 
Disorders of skin
Disorders of skinDisorders of skin
Disorders of skin
 
Atopic dermatitis by Dr.Gamal Soltan
Atopic dermatitis by Dr.Gamal SoltanAtopic dermatitis by Dr.Gamal Soltan
Atopic dermatitis by Dr.Gamal Soltan
 
Ethics & Dermatology
Ethics & Dermatology Ethics & Dermatology
Ethics & Dermatology
 
urticaria and skin allergy tests.pptx
urticaria and skin allergy tests.pptxurticaria and skin allergy tests.pptx
urticaria and skin allergy tests.pptx
 
pyoderma.pptx
pyoderma.pptxpyoderma.pptx
pyoderma.pptx
 
Atopic dermatitis(Eczema)
Atopic dermatitis(Eczema)Atopic dermatitis(Eczema)
Atopic dermatitis(Eczema)
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Skin infection .pdf
Skin infection .pdfSkin infection .pdf
Skin infection .pdf
 
ATOPIC DERMATITIS in children. dx and tx
ATOPIC DERMATITIS in children. dx and txATOPIC DERMATITIS in children. dx and tx
ATOPIC DERMATITIS in children. dx and tx
 
AD.pptx
AD.pptxAD.pptx
AD.pptx
 
7 Dermatitis.pptx
7 Dermatitis.pptx7 Dermatitis.pptx
7 Dermatitis.pptx
 
ATOPIC DERMATITIS, diagnosis &management
ATOPIC DERMATITIS, diagnosis &managementATOPIC DERMATITIS, diagnosis &management
ATOPIC DERMATITIS, diagnosis &management
 
Leprosy_٢.pptx
Leprosy_٢.pptxLeprosy_٢.pptx
Leprosy_٢.pptx
 

More from ShahadMu2

2_5235994982740928957.pdf
2_5235994982740928957.pdf2_5235994982740928957.pdf
2_5235994982740928957.pdf
ShahadMu2
 
عرض تقديمي.pptx
عرض تقديمي.pptxعرض تقديمي.pptx
عرض تقديمي.pptx
ShahadMu2
 
المستند (1).docx
المستند (1).docxالمستند (1).docx
المستند (1).docx
ShahadMu2
 
المستند.docx
المستند.docxالمستند.docx
المستند.docx
ShahadMu2
 
2_5265247068691112037.pdf
2_5265247068691112037.pdf2_5265247068691112037.pdf
2_5265247068691112037.pdf
ShahadMu2
 
2_5269673406151796511.pdf
2_5269673406151796511.pdf2_5269673406151796511.pdf
2_5269673406151796511.pdf
ShahadMu2
 

More from ShahadMu2 (6)

2_5235994982740928957.pdf
2_5235994982740928957.pdf2_5235994982740928957.pdf
2_5235994982740928957.pdf
 
عرض تقديمي.pptx
عرض تقديمي.pptxعرض تقديمي.pptx
عرض تقديمي.pptx
 
المستند (1).docx
المستند (1).docxالمستند (1).docx
المستند (1).docx
 
المستند.docx
المستند.docxالمستند.docx
المستند.docx
 
2_5265247068691112037.pdf
2_5265247068691112037.pdf2_5265247068691112037.pdf
2_5265247068691112037.pdf
 
2_5269673406151796511.pdf
2_5269673406151796511.pdf2_5269673406151796511.pdf
2_5269673406151796511.pdf
 

Recently uploaded

Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
Kartik Tiwari
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 

Recently uploaded (20)

Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 

المستند (4).docx

  • 2. Dermatitis: greek word- derma + itis = INFALMMATION OF SKIN Etymology: Atopic derived from atopia in greek = UNUSUALNESS 2
  • 3. AN ITCHY, CHRONIC OR CHRONICALLY RELAPSING SKIN CONDITION OFTEN STARTING EARLY IN CHILHOOD WITH RASH CHARACTERIZED BY ERYTHEMA , ITCHY PAPULES/ PAPULOVESICLES WHICH MAY BECOME EXCORIATED AND LICHENIFIED . DEFINITION 3
  • 4. Inside outside model Outside inside model Skin barrier dysfunction Immunologic abnormality in skin Skin barrier dysfunction Epicutaneous allergen penetration Immune system activation 5 Etiopathgenesis
  • 6. Hygiene Hypothesis 13  Early childhood infections caused by unhygienic contact with older siblings confers protection from development of allergic diseases  Farm effect- children living on farms, having contact with farm animals, drinking unprocessed cow`s milk, increased exposure to microbes have less incidence of AD and asthma.
  • 7. Trigger factors 14 1) Changes in temperature 2) Sweating 3) Decrease in huminity 4) Contact with irritants 5) Aeroallergens 6) Food allergens 7) Emotional stress 8) harmones
  • 8. Clinical features Atopic dermatitis Infantile phase • Birth to 2 years • Cheeks • chin • forehead Childhood phase • to 12 2 years • Elbow and knee folds • Wrists • ankles Adult phase • 12 years to adults • Flexural lichenifi 15
  • 10.
  • 11.
  • 14.
  • 16.
  • 17. Hanifin & Rajka criteria for the diagnosis of AD 25 Major criteria( must have three or more) 1. Pruritus 2. Typical morphology & distribution  Facial/extensor involvement in infants & children  Flexural lichenification in adults 3. Chronic or chronically relapsing dermatitis 4.Personal or family history of atopy(Asthma, allergic rhinitis, atopic dermatitis)
  • 18. The UK refinement of Hanifin & Rajka’s diagnostic criteria of atopic dermatitis(Eczema) 28 Essential criteria An itchy skin condition(or parental report of scratching or rubbing in a child) Plus three more or following: 1. Onset below age of 2 years(not used if child is under 4 years) 2. History of skin crease involvement(including cheeks in children under 10 years) 3. History of a generally dry skin 4. Personal history of other atopic disease(or history of any atopic disease in a first-degree relative in children under 4 years)
  • 19. 5. Visible flexural dermatitis(or dermatitis of cheeks/forehead & outer limbs in children under 4 years)
  • 20. Millennium criteria 29 Mandatory criteria(must be fulfilled) 1. Allergen specific IgE Principal criteria(must have two or more) 1. Pruritis 2. Typical morphology & distribution 3. Chronic & relapsing course
  • 21. 33 b) Age related characteristics  Infantile phase-starts on scalp & face, often spreads to trunk & extremity  Childhood phase- neck, flexural surface of arms & legs  Adolescent/adult phase-tendency to be severe, on upper half of the body (iii) Chronic or chronically relapsing course:  More than 2 months in infancy  More than 6 months in childhood, adolescence & adulthood
  • 22. AMERICAN ACADEMY OF DERMATILOGY 34 Guidelines of care for management of AD
  • 23. Recommendation for non pharmacologic interventions for the treatment of atopic dermatitis 35  Moisturizers should be an integral part of the treatment.  Bathing is suggested for the patient with AD as part of treatment &maintenance  Moisturizers should be applied soon after bathing  Limited use of non soap cleansers is recommended  The additions of oils, emollients & most other additives to bath waters cannot be recommended  Use of wet-wrap therapy with or without a topical corticosteroid can be recommended for patient with moderate to severe AD to decrease disease severity & water loss during flares.
  • 24. Recommendation for the use of topical corticosteroids for the treatment of atopic dermatitis. 36  Recommended for AD-affected individuals who have failed to respond to good skin care & regular use of emollients alone.  A variety of factors should be considered including patient age, body area , & other patient factors such as degree of xerosis, patient preference & cost of medication  Twice daily application of corticosteroids is generally recommended  Proactive intermittent use of topical corticosteroids as maintenance therapy(1-2 times/wk) on area that commonly flare is recommended to help prevent relapses
  • 25. & is more effective than use of emollients alone
  • 26.
  • 27. 39 Topical antimicrobials and antiseptics 40 Except for bleach baths with intranasal mupirocin, no topical antistaphylococcal treatment has been shown to be clinically helpful in patient with AD & is not routinely recommended. In patient with moderate to severe AD & clinical signs of secondary bacterial infection, bleach baths & intranasal mupirocin may be recommended to reduce disease severity
  • 28. Topical antihistamines 41 The use of topical antihistamines for the treatment of patients with atopic dermatitis is not recommended because of the risk of absorption & of contact dermatitis.